Journal
NATURE BIOTECHNOLOGY
Volume 20, Issue 9, Pages 908-913Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt725
Keywords
-
Categories
Funding
- NIGMS NIH HHS [GM56552] Funding Source: Medline
Ask authors/readers for more resources
We describe a method for the rational design of more effective therapeutic proteins using amino acid substitutions that reduce receptor binding affinity in intracellular endosomal compartments, thereby leading to increased recycling in the ligand-sorting process and consequently resulting in longer half-life in extracellular medium. We demonstrate this approach for granulocyte colony-stimulating factor by using computationally predicted histidine substitutions that switch protonation states between cell-surface and endosomal pH. Molecular modeling of binding electrostatics indicates two different single-histidine mutants that fulfill our design requirements; experimental assays demonstrate that each mutant indeed exhibits an order-of-magnitude increase in medium half-life along with enhanced potency due to increased endocytic recycling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available